Login
Navigate Fool.com
Will MRK beat
the market?

Merck & Co., Inc.

NYSE: MRK

Community Rating: 3 Stars: Appealing

57.53 0.03 (0.05%)

REAL-TIME: Last trade at

Extended Hours: $57.45 -$0.08 (-0.14%)
Quote as of (NYSE)


company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $57.32
Previous Close $57.50
Daily Range $56.85 - $57.82
52-Week Range $44.60 - $58.32
Market Cap $169.2B
P/E Ratio 39.12
Dividend (Yield) $1.76 (3.1%)
Ex-Dividend Date
Dividend Pay Date
03/13/14
04/07/14
Volume 6,606,337
Average Daily Volume 11,382,397
Current FY EPS $3.46

How do you think MRK
will perform against the market?

Top MRK Bull/Bear Pitches

 

alcear (< 20)
Submitted April 29, 2011

rotation into healthcare

0 Replies Reply Report this Post
 

nitraMcoD (3.53)
Submitted August 25, 2006

There are fundamental shifts occurring in the industry that will eat away at the efficiencies MRK currently enjoys. While their response to these shifts will be correct, their size will slow down thei … More

0 Replies Reply Report this Post

News & Commentary

Will These 3 Dividend Stocks Impress Investors This Earnings Season?

Bristol-Myers Squibb, Merck, and Pfizer all face challenges in their coming earnings releases. Will these stocks live up to expectations?

Noteworthy ETF Outflows: PJP, LLY, MRK, AMGN

Say Hello to the New Fastest Growing Drug in History!

This drug absolutely shattered Vertex Pharmaceuticals' record for bringing a new drug to market and hitting the $1 billion sales plateau, accomplishing the feat in just a quarter.

A Doozy of a Pharma Rumor

Pfizer was reportedly interested in buying AstraZeneca taking us back to an era of mega-mergers such as Pfizer-Wyeth and Merck-Schering-Plough.

Why Johnson & Johnson Is Outperforming the Dow

J&J has crushed the Dow Jones Industrials so far this year. Can it continue to outperform?

I have no qualms about taking Gilead’s $84,000 drug

Dow Climbs As Pharma Stocks Jump, but Will Drug M&A Hurt UnitedHealth?

The Dow kept rising steadily today, but big news in the health-care industry could have an impact on the Dow in the longer term.

Pfizer, Inc. Rebuffed: Is AstraZeneca plc Worth Another Try?

Pfizer's rumored deal for AstraZeneca would be a bold bid for scale in oncology and immunology

Big Pharma Deal? No; As Usual, Trade The Reaction, Not The News

Johnson & Johnson's New Diabetes Drug: A Blockbuster in the Making?

Johnson's Invokana is about to face a host of new SGLT2 competitors from AstraZeneca, Merck, and Eli Lilly.

See More MRK News...

Sector

Healthcare

Industry

Drugs

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website: http://www.merck.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks